2.63
1.50%
-0.04
Pasithea Therapeutics Corp Azioni (KTTA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Selling, General, and Administrative
|
27.51%
2.2916
|
1.7972 | 2.1646 | 1.8005 | 2.1163 |
Operating Income/Loss |
21.52%
-4.0408
|
-5.1488 | -3.7893 | -3.8287 | -3.2126 |
Nonoperating Income/Loss |
0.1799
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
23.26%
-3.8608
|
-5.0313 | -3.6126 | -3.5981 | -3.2658 |
Income/Loss From Continuing Operations After Tax |
23.26%
-3.8608
|
-5.0313 | -3.6126 | -3.5981 | -3.2658 |
Net Income/Loss
|
23.52%
-3.8608
|
-5.0482 | -3.6126 | -3.7632 | -3.5377 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
104.25%
1.0425
|
-24.56 | 25.16 | 26.13 | 26.07 |
Diluted Average Shares |
104.25%
1.0425
|
-24.56 | 25.16 | 26.13 | 26.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):